Perceives Failure
"If I'm put on insulin, I must be doing something wrong."
- Perceives Failure

The use of Certified Diabetes Educators (CDEs) may help implement a DSME/T model in your practice

You may want to have the insulin talk sooner

Diabetes Self-Management Education/Training (DSME/T) may help patients improve glycemic control.

In the U.S., approximately 50% of people with diabetes participate in formal diabetes education.1



Rethinkinsulin.com In the U.S., approximately 50% of people with diabetes participate in formal diabetes education

The overall objectives of DSME/T are to give patients the knowledge, skill, and ability necessary for diabetes self-care. This process incorporates the needs, goals, and life experiences of the person with diabetes and is guided by evidence-based standards.1

For T2DM patients struggling with uncontrolled blood glucose, your practice may benefit from DSME/T. It has been recognized that a range of DSME/T interventions may help improve diabetes management.1

National standards for DSME/T define and address the quality of diabetes self-management education:

  • Standards are reviewed every 5 years to incorporate updated evidence-based knowledge1
  • Task force for DSME/T standards include the ADA, American Association of Diabetes Educators (AADE), industry organizations, and federal agencies1

The use of Certified Diabetes Educators (CDEs) may help implement a DSME/T model in your practice. The collaboration between your healthcare team and CDEs may help improve diabetes management for your T2DM patients.

Next >

Important Safety Information for Lantus®

Contraindications

Lantus® is contraindicated in patients hypersensitive to insulin glargine or one of its excipients.

Warnings and precautions

Monitor blood glucose in all patients treated with insulin. Insulin regimens should be modified cautiously and only under medical supervision. Changes in insulin strength, manufacturer, type, or method of administration may result in the need for a change in insulin dose or an adjustment in concomitant oral antidiabetic treatment.

Do not dilute or mix Lantus® with any other insulin or solution. If mixed or diluted, the solution may become cloudy, and the onset of action/time to peak effect may be altered in an unpredictable manner. Do not administer Lantus® via an insulin pump or intravenously because severe hypoglycemia can occur. Insulin devices and needles must not be shared between patients.

Hypoglycemia is the most common adverse reaction of insulin therapy, including Lantus®, and may be life-threatening.

Severe life-threatening, generalized allergy, including anaphylaxis, can occur.

A reduction in the Lantus® dose may be required in patients with renal or hepatic impairment.

Drug interactions

Certain drugs may affect glucose metabolism, requiring insulin dose adjustment and close monitoring of blood glucose. The signs of hypoglycemia may be reduced in patients taking anti-adrenergic drugs (e.g., beta-blockers, clonidine, guanethidine, and reserpine).

Adverse reactions

Other adverse reactions commonly associated with Lantus® are injection site reaction, lipodystrophy, pruritus, and rash.

Important Safety Information for Lantus® SoloSTAR®

Lantus® SoloSTAR® is a disposable prefilled insulin pen. To help ensure an accurate dose each time, patients should follow all steps in the Instruction Leaflet accompanying the pen; otherwise they may not get the correct amount of insulin, which may affect their blood glucose.

Indications and Usage for Lantus®

Lantus® is a long-acting insulin analog indicated to improve glycemic control in adults and children (6 years and older) with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. Lantus® should be administered once a day at the same time every day.

Important Limitations of Use: Lantus® is not recommended for the treatment of diabetic ketoacidosis. Use intravenous short-acting insulin instead.

Please click here for full prescribing information

References: 1. Duncan I, et al. The Diabetes Educator 2009; 35; 752